Organigram (TSE:OGI – Get Free Report) is set to announce its earnings results before the market opens on Tuesday, August 13th. Analysts expect the company to announce earnings of C($0.07) per share for the quarter.
Organigram (TSE:OGI – Get Free Report) last posted its quarterly earnings results on Tuesday, May 14th. The company reported C($0.16) earnings per share for the quarter, missing the consensus estimate of C($0.08) by C($0.08). Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%. The company had revenue of C$37.63 million for the quarter, compared to analyst estimates of C$38.20 million.
Organigram Stock Up 2.4 %
OGI opened at C$2.10 on Wednesday. Organigram has a 1-year low of C$1.35 and a 1-year high of C$3.95. The stock’s fifty day simple moving average is C$2.21 and its 200 day simple moving average is C$2.53. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.55. The stock has a market cap of C$216.30 million, a PE ratio of -0.84, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13.
Insider Transactions at Organigram
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the company. Jefferies Financial Group reduced their target price on Organigram from C$4.40 to C$4.35 in a report on Friday, May 17th. Canaccord Genuity Group reduced their target price on Organigram from C$3.75 to C$3.25 and set a “speculative buy” rating on the stock in a report on Wednesday, May 15th.
Check Out Our Latest Stock Analysis on OGI
About Organigram
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Featured Articles
- Five stocks we like better than Organigram
- How to Use the MarketBeat Excel Dividend Calculator
- Lumen’s Q2: Can AI Revenue Outshine a Mountain of Debt?
- What Are Dividend Challengers?
- Carry Trade Ending: Recent Market Turbulence and Future Risks
- Airline Stocks – Top Airline Stocks to Buy Now
- Stocks Slide: Trillions Lost, More Downside Ahead?
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.